advanced glycation end-products glutathione End Products in Disease Development and Potential Interventions A Role for Advanced Glycation

(Reference Li, Chen and Aldini64) DB: Double-blind/NR: Not reported/T2DM: Type 2 diabetes mellitus/MetS: Metabolic syndrome/ PCOS: Polycystic ovary syndrome/NAFLD: Non-alcoholic fatty liver disease/MS: Multiple Sclerosis/M: male/F: female/CRP: C-reactive protein/TNF-a: Tumour necrosis factor-a/IL: Interleukin/TAC: Total antioxidant capacity/MDA: Malondialdehyde/GPx: Glutathione peroxidase/SOD: Superoxide dismutase

Observe patients for at least 2 hours after the last dose of naloxone and use the clinical prediction tool for disposition decisions

Heat shock pretreatment of mesenchymal stem cells for inhibiting the apoptosis of ovarian granulosa cells enhanced the repair effect on chemotherapy-induced premature ovarian failure

For example, most cytotoxic payloads are hydrophobic and linking these payloads to mAbs that contain additional hydrophobic properties usually cause ADC aggregation, which limits the drug loading content on antibodies